Gene · 2673
Papers1,425
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,425
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| GFPT1 facilitates immune escape in breast cancer by promoting the OGT-mediate O-GlcNAcylation of CD39. | Autoimmunity | 2025 | 41355137 | PubTator, text mining | PubMed |
| Expanding the phenotypic and imaging spectrum of GFPT1-related congenital myasthenic syndromes: a Brazilian case series. | Front Neurol | 2025 | 41323224 | PubTator, text mining | PubMed |
| Druggable Genome Mendelian Randomization and GWAS-sceQTLs MR Analysis Reveal Genetic Associations Between Open-Angle Glaucoma and Immune Cells, and Identify Potential Drugs. | Transl Vis Sci Technol | 2025 | 41165397 | PubTator, text mining | PubMed |
| Comprehensive investigation of the molecular basis of cancer dependencies suggests therapeutic options for breast cancer. | Cancer Biol Med | 2025 | 41131861 | PubTator, text mining | PubMed |
| O-GlcNAcylation Stabilizes NEK7 to Drive Podocyte Pyroptosis in Diabetic Kidney Disease. | Diabetes | 2025 | 41100887 | PubTator, text mining | PubMed |
| The spectrum of neuromuscular diseases with tubular aggregates. | Neuromuscul Disord | 2025 | 41072378 | PubTator, text mining | PubMed |
| Myosin-actin pattern links matrix stiffness to GFAT2-hyaluronan metabolism. | Mater Today Bio | 2025 | 41019491 | PubTator, text mining | PubMed |
| The hexosamine biosynthetic pathway drives tumor immune evasion via translational control of PD-L1 at the elongation level. | Cell Rep | 2025 | 40938752 | PubTator, text mining | PubMed |
| A Cross-Tissue Transcriptome-Wide Association Study Identified Susceptibility Genes for Intervertebral Disc Degeneration. | JOR Spine | 2025 | 40922807 | PubTator, text mining | PubMed |
| Disruption of egg and nymph development via RNAi-mediated Glutamine: fructose-6-phosphate aminotransferase knockdown in Locusta migratoria: A promising strategy for pest management. | Pestic Biochem Physiol | 2025 | 40915821 | PubTator, text mining | PubMed |
| Impacts of aging and fluid shear stress on vascular endothelial metabolism and atherosclerosis development. | J Biomed Sci | 2025 | 40890841 | PubTator, text mining | PubMed |
| Integrating large-scale in vitro functional genomic screen and multi-omics data to identify novel breast cancer targets. | Breast Cancer Res Treat | 2025 | 40888991 | PubTator, text mining | PubMed |
| GFAT1 promotes the progression of hepatocellular carcinoma via enhancing the O-GlcNAcylation of VEZF1. | Cell Death Dis | 2025 | 40858565 | PubTator, text mining | PubMed |
| Early functional changes in lewy body dementia: roles of dynamics, locus coeruleus, and compensation. | Alzheimers Res Ther | 2025 | 40849483 | PubTator, text mining | PubMed |
| Exploring the metabolic signaling network of GFPT in cancer. | Cell Death Discov | 2025 | 40830088 | PubTator, text mining | PubMed |
| Phosphoproteomic insights into GFPT2-Associated cellular phospho-signaling networks. | Biochem Biophys Rep | 2025 | 40808719 | PubTator, text mining | PubMed |
| Integrated Transcriptome and Metabolome Analyses Uncover Cholesterol-Responsive Gene Networks. | Int J Mol Sci | 2025 | 40806239 | PubTator, text mining | PubMed |
| Combinational Analysis of Metabolomic and O-GlcNAcylation Omics Reveals the HBP Metabolic Regulation of Chemoresistance via GFPT1/NR3C1 O-GlcNAcylation/GPX4 Axis. | Research (Wash D C) | 2025 | 40740652 | PubTator, text mining | PubMed |
| Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches. | Signal Transduct Target Ther | 2025 | 40739089 | PubTator, text mining | PubMed |
| Cross-Tissue Transcriptome-Wide Association Study Identifies Novel Genes Associated With POAG. | Invest Ophthalmol Vis Sci | 2025 | 40459497 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2673/papers?page=3